Assessing CMMI’s proposals on Medicaid payment for cell and gene therapies
Brookings,
Recent years have seen the arrival of a wave of new therapies that use living cells or genetic material to treat disease, which…
Recent years have seen the arrival of a wave of new therapies that use living cells or genetic material to treat disease, which…
Numerous Commercial Advances By mid-2022, there were eight cell and gene therapies approved by the U.S.
Cell and gene therapy manufacturing may never be standardized but the whole industry would gain if firms collaborated to…
Introduction Regenerative medicine (RM), which promises to cure disease and respond to currently unmet medical needs [ 1 ], is…
Although the advent of cell and gene therapies is revolutionizing medicine, it is arguable that the therapies that have been…